ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01EA04 | B | Bosutinib - 400mg | 9911 | 60619/1 | BOSULIF | 400mg | 28 | Tablet, film coated | Oral | Droguerie Fattal S.A.L. | Pfizer Manufacturing Deutschland GmbH | Germany | 239,947,197 L.L | 2.44 | E2 | Pfizer Europe MA EEIG | Belgium | 2/5/2024 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01EA04 | B | Bosutinib - 400mg | 9911/388 | 60619/1 | BOSULIF | 400mg | 28 | Tablet, film coated | Oral | Droguerie Fattal S.A.L. | Pfizer Manufacturing Deutschland GmbH | Germany | L.L | 2.44 | E2 | Pfizer Europe MA EEIG | Belgium | 2/5/2024 |